← Open Payments lookup

YUAN ZHAO: Open Payments

NPI 1679122592 · EL SEGUNDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,485 in 97 payments from 22 companies in 2025. Trend: 2023 $891 · 2024 $1,651 · 2025 $2,485

Food & beverage: $2,400Education: $85
CompanyPaymentsAmount
Novo Nordisk Inc16$345
Ascendis Pharma Endocrinology Inc11$335
Amgen Inc.6$262
Ascensia Diabetes Care Us Inc.15$189
Lilly USA, LLC7$182
Boehringer Ingelheim Pharmaceuticals, Inc.6$170
Averitas Pharma Inc.5$158
Novartis Pharmaceuticals Corporation4$129
Mannkind Corporation3$110
Tandem Diabetes Care, Inc.4$109

Products named: Yorvipath, JARDIANCE, Wegovy, MOUNJARO, QUTENZA, Ozempic, LEQVIO, REPATHA.

Industry payments across CA — which companies pay providers there.